2nd Quarter - Report

340B HEALTH for 340B HEALTH

Period 2nd Quarter 2010 Filed Jul 20, 2010 Signed by Robert Recklaus Director of Government Relations

Official filing
Firm
340B HEALTH
Client
340B HEALTH
Income
—
Expenses
$191,519
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S. 1239; H.R. 444; H.R. 4213; Extending 340B Drug Discount Program to the inpatient setting in eligible hospitals and improving program integrity. Preserving current 340B patient definition; Improving Medicaid reimbursement to 340B covered entities; reversing 340B orphan drug prohibition for certain covered entities.

LobbyistCovered position, as disclosed
ROBERT RECKLAUS Staff for Rep. McCarthy (02-08)
TED SLAFSKY Fellow for Dem Policy Committee 1994
JAIMIE VICKERY Staff for Reps. Horn and Biggert (01-05)
WILLIAM VON OEHSEN —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 444 (111th), S. 1239 (111th), H.R. 4213 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.